According to reports from Business Standard and ETEnterpriseai, Tata Elxsi announced the launch of AnaTel, an AI-native software development platform for healthcare and medical technology companies. The platform was co-developed with OpenAna, a provider of autonomous AI engineering platforms, through STEP.UP, Tata Elxsi's co-innovation program for high-potential deep-tech companies. AnaTel made its debut at DeviceTalks Boston 2026, where Tata Elxsi is presenting its latest advances in AI-powered MedTech engineering and compliance. As per ETEnterpriseai, the platform was officially launched on Wednesday, combining Tata Elxsi's experience in regulated medical device software engineering with OpenAna's autonomous AI engineering platform capabilities.
As reported by Business Standard and ETEnterpriseai, healthcare and medtech software teams face growing operational challenges due to rising regulatory expectations for AI-enabled device software. The FDA's 2025 draft guidance on AI-Enabled Device Software Functions and Europe's MDCG 2025-26 both require rigorous lifecycle documentation, traceability, and validation evidence as part of core engineering workflows, not submission afterthoughts. This results in familiar bottlenecks where requirements, test cases, traceability matrices, and regulatory artifacts are assembled manually across disconnected tools. The evolving regulatory frameworks are increasing compliance requirements for AI-based healthcare software systems, creating significant operational challenges for healthcare software teams. Every software change becomes a documentation exercise, and every submission cycle starts from scratch.
According to Business Standard and ETEnterpriseai, AnaTel addresses these challenges by embedding autonomous AI agents directly into the engineering workflow. Unlike developer productivity tools that focus on code generation alone, AnaTel operates across the full AI-Driven Software Delivery Lifecycle, from requirements and architecture through deployment, verification and validation, and continuous optimization. The platform functions as a configurable AI software engineering team capable of generating code, documentation, test cases, and regulatory artifacts using a dedicated Healthcare and Life Sciences expert agent fine-tuned for medtech regulatory and engineering contexts. Human engineers and regulatory experts remain in control at every critical review and decision point, ensuring regulatory compliance while maintaining human oversight. The platform supports eSTAR-aligned submission preparation, requirements traceability matrices, verification and validation evidence, and audit-trail documentation as part of day-to-day engineering workflows.
As reported by Business Standard and ETEnterpriseai, the platform is expected to reduce SaMD development and change assessment timelines from eight weeks to 72 hours, with productivity improvements of up to 60%. AnaTel operates as a true end-to-end engineering execution platform for regulated environments, drawing on Tata Elxsi's extensive experience building software in highly regulated medical device environments. The platform's engineering depth has shaped how it reasons about traceability, validation, and compliance, not just how it is deployed. Tata Elxsi brings design-led and AI-first engineering, deep domain expertise, and access to global healthcare and medtech enterprises, while OpenAna contributes platform and technology innovation through its Ana Platform of Autonomous Engineers spanning software engineering, security, DevOps/SRE, and AI/ML.
According to recent reports, Sreevatsa Sahasranaman, senior vice president and head of healthcare and life sciences at Tata Elxsi, emphasized that AnaTel accelerates regulatory-ready software engineering by bringing autonomous AI agents directly into development workflows that shape compliance and submission readiness, while keeping customers' engineering and regulatory experts firmly in control. Rajiv Sondhi, chief executive officer of OpenAna, highlighted their mission to provide autonomous AI agents that work as reliable co-engineers alongside human teams, noting that partnering with Tata Elxsi brings this capability into one of the most demanding domains where lifecycle traceability, safety, and compliance are as important as speed. Muthusamy Selvaraj, VP of innovation and partnerships at Tata Elxsi, emphasized that their accountability for the outcome makes this model different from traditional approaches.
